Thus, an increase in NRF2 activity, reflected by induction of NRF2 target genes, likely represent an important mechanism mediating the protection seen in GCLM KO mice
GLP-1 receptor agonists enhance glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and reduce appetite through hypothalamic signaling [10]
By targeting both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors, it mimics two natural hormones instead of one
After surgery, youll likely have some swelling and fluid retention
The FDA cleared orforglipron for chronic weight management in adults with obesity, or overweight with at least one weight-related comorbidity, based on the ATTAIN clinical program which showed placebo-adjusted weight loss of 7.5% to 11.2% in non-diabetics (ATTAIN-1) and 5.1% to 9.6% in diabetics at different doses, along with the expected glycaemic benefits (ATTAIN-2)
Actives that disrupt the barrier, cause irritation, or cannot be used consistently tend to fail, not because they dont work, but because skin cant sustain them
